2C-Ph

Uses your system voice; voice and rate in settings.

Snapshot

≈ 11 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Pharmaceutical compound

2C-Ph, or 2C-Phenyl, also known as 2C-BI-1 or as 2,5-dimethoxy-4-phenylphenethylamine, is a serotonin receptor modulator of the phenethylamine and 2C families that was developed by Daniel Trachsel and David E. Nichols and colleagues.[1][2][3][4]

The drug's affinity (Ki) for the rat serotonin 5-HT2A receptor was 778 nM.[1][2] It was said to be an antagonist of this receptor.[1][2][4] In a subsequent study, 2C-Ph was a weak partial agonist of the human serotonin 5-HT2A receptor (Ki = 630 nM, EC50Tooltip half-maximal effective concentration = 1,596 nM, EmaxTooltip maximal efficacy = 23%).[3] The drug also shows affinity for the serotonin 5-HT1A, 5-HT2B, and 5-HT2C receptors, but did not activate the serotonin 5-HT2B receptor.[3] In addition, it interacted with other monoamine receptors, with the monoamine transporters, and was a potent and high-efficacy partial agonist of the human trace amine-associated receptor 1 (TAAR1) (EC50 = 580 nM, Emax = 82%).[3]

Besides 2C-Ph itself, a variety of derivatives of 2C-Ph with substituents on the 4-position phenyl ring have been synthesized and studied by Trachsel and colleagues.[1][2][3] These drugs, inclusive of 2C-Ph, have been denoted 2C-BI-1 to 2C-BI-12.[1][2][3] 2C-BI-4 (the 2′-trifluoromethyl derivative), 2C-BI-8 (the 4′-methoxy derivative), and 2C-BI-12 (the 3′,4′-dimethoxy derivative) are agonists of the human serotonin 5-HT2A receptor with higher efficacy than 2C-Ph (EC50 = 37–2,408 nM, Emax = 38–44%).[3] The effects of 2C-Ph and its derivatives in humans are unknown.[1][3] However, 2C-BI-8 and 2C-BI-12 might have the potential for psychedelic effects.[3]

2C-Ph was first described in the scientific literature, by Trachsel and Nichols and colleagues, in 2009.[1][2] It is a controlled substance in Canada under phenethylamine blanket-ban language.[5]

See also

edit edit source

References

edit edit source
  1. ^ a b c d e f g Trachsel D, Lehmann D, Enzensperger C (2013). Phenethylamine: von der Struktur zur Funktion [Phenethylamines: From Structure to Function]. Nachtschatten-Science (in German). Solothurn: Nachtschatten-Verlag. p. 806. ISBN 978-3-03788-700-4. OCLC 858805226. Retrieved 29 January 2025.
  2. ^ a b c d e f Trachsel D, Nichols DE, Kidd S, Hadorn M, Baumberger F (May 2009). "4-aryl-substituted 2,5-dimethoxyphenethylamines: synthesis and serotonin 5-HT(2A) receptor affinities". Chemistry & Biodiversity. 6 (5): 692–704. doi:10.1002/cbdv.200800235. PMID 19479848.
  3. ^ a b c d e f g h i Luethi D, Widmer R, Trachsel D, Hoener MC, Liechti ME (July 2019). "Monoamine receptor interaction profiles of 4-aryl-substituted 2,5-dimethoxyphenethylamines (2C-BI derivatives)". European Journal of Pharmacology. 855: 103–111. doi:10.1016/j.ejphar.2019.05.014. PMID 31063768.
  4. ^ a b Yempala T, Brea J, Loza MI, Matthies DJ, Zapata-Torres G, Cassels BK (February 2020). "Dibenzofuranylethylamines as 5-HT2A/2C Receptor Agonists". ACS Omega. 5 (5): 2260–2266. doi:10.1021/acsomega.9b03430. PMC 7016908. PMID 32064387. Regarding the weakly binding compound 3, which is practically devoid of (partial) agonist activity at both receptor subtypes, it may be seen as a cyclized version of the 5-HT2A antagonist 2-(2,5-dimethoxy-4-phenylphenyl)ethanamine (2C-phenyl, compound 7 in Trachsel et al., 2009).23 However, the orientation of the oxygen lone pairs on the dibenzofuran ring is "wrong" for hydrogen bonding,6,7 as corroborated by the higher affinities of 2C-phenyl and the "Fly" and "Dragonfly" compounds with "correct" orientations and pKi values of 6.11 and greater than 8, respectively, at the 5-HT2A receptor (the 5-HT2C affinities of 2C-phenyl and the "Fly/Dragonfly" compounds are not available, nor are their functional activities at this receptor). Nevertheless, it should be noted, however, that while 2C-H-Fly elicited a positive drug discrimination response in LSD-trained rats, suggesting that it is a 5-HT2A agonist, and 3 is a very weak partial agonist, 2C-phenyl is an antagonist at this receptor (Figure 6). [...] Figure 6. Comparison of the structures of compound 3, 2C-phenyl, and "Fly" (with dihydrofuran rings) and "Dragonfly" compounds (with furan rings).
  5. ^ "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
edit edit source Serotonin receptor modulators5-HT1 5-HT1B 5-HT1D 5-HT1E 5-HT1F 5-HT2 5-HT2B 5-HT2C 5-HT3–7 5-HT4 5-HT5A 5-HT6 5-HT7 Trace amine-associated receptor modulatorsTAAR1Tooltip Trace amine-associated receptor 1 Antagonists Inverse agonists TAAR5Tooltip Trace amine-associated receptor 5 Notes: (1) TAAR1 activity of ligands varies significantly between species. Some agents that are TAAR1 ligands in some species are not in other species. This navbox includes all TAAR1 ligands regardless of species. (2) See the individual pages for references, as well as the List of trace amines, TAAR, and TAAR1 pages.
See also: Receptor/signaling modulators PhenethylaminesPhenethylamines Amphetamines Phentermines Cathinones Phenylisobutylamines
(and further-extended) Catecholamines
(and close relatives) Cyclized
phenethylamines
Related compounds

Text derived from https://en.wikipedia.org/w/index.php?oldid=1365954840 under CC BY-SA 4.0; modifications have been made.